RxDoctor Payments Data

Stacey Carter, MD

Urology · Santa Monica, CANPI 1619248184

Payments from drug & device makers

$1,049in general payments, 2019–2025

Across 36 payments — averaging $29.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$312
  • Rochester Medical Corporation$298
  • Cook Medical LLC$185
  • Calyxo, Inc.$139
  • BD$65
  • Coloplast$28
  • plus $22 from 1 others

What the payments were for

  • Food & beverage$1,049100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific2$312
Rochester Medical Corporation26$298
Cook Medical LLC2$185
Calyxo, Inc.1$139
BD3$65
Coloplast1$28
C. R. Bard, Inc. & Subsidiaries1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,049 in reported general payments places this provider in the 35th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$7,468
Medicare patients
15
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron66$55,813
Mirabegron ErMirabegron31$14,477
Potassium Citrate ErPotassium Citrate112$8,221
Terazosin Hcl137$6,302
Tamsulosin Hcl312$5,237
Finasteride258$3,931
Trospium Chloride44$1,941
Estradiol32$1,485
Tadalafil29$657
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst27$340
Ciprofloxacin Hcl25$214
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$214
Allopurinol15$206
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$177
Chlorthalidone11$110

Paid to pharmacies, not to this prescriber.

Other urology in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →